Actor Noel Clarke pleads not guilty to sexual offence charges

Actor and writer Noel Clarke has pleaded not guilty to sexual offence charges at Westminster Magistrates’ Court, where a trial date was set for early next year as the former Doctor Who star seeks to clear his name following a complaint made last month.

Court proceedings

BBC News reports that Clarke, 50, appeared before district judge Amanda Cox on Wednesday, confirming his plea of not guilty on three counts of sexual assault and one count of causing a person to engage in sexual activity without consent. The prosecution outlined its intention to call four witnesses, with the alleged incidents said to date back to 2023 on a film set in north London.

Why it matters

The case has become a focal point in the wider conversation about misconduct in the UK entertainment industry, coming as the Screen Actors Guild and the broadcasting union BECTU continue to field new complaints. For Clarke, whose career spans from the ITV series Prime Suspect to his recent role as a producer on several streaming dramas, the outcome could reshape ongoing and future projects, including a BBC commission that was due to enter pre-production next spring.

Career impact and industry reaction

Since the charges were first reported, two production companies have publicly distanced themselves from upcoming Clarkescreen productions, though neither the BBC nor ITV have confirmed whether they will continue to distribute his back catalogue of programmes. His talent agency, United Agents, confirmed that it remains “legally represented” while the matter proceeds, stopping short of dropping his representation.

What happens next

The matter returns to Westminster Magistrates’ Court for a plea and case management hearing in January, with a full trial listed for February at Southwark Crown Court. Legal experts say the high-profile nature of the case means it will be heard without a jury, a departure from standard practice that the judge justified on grounds of protecting the accused and witnesses. Coverage is expected to remain restricted until the trial begins.